Adverse hematologic effects of ticlopidine
Lesesve, J.F.; Noblet, C.; Stamatoullas, A.; Gueit, I.; Moore, N.; Monconduit, M.
Therapie 50(5): 468-470
1995
ISSN/ISBN: 0040-5957 PMID: 8571290 Document Number: 443772
Document emailed within 1 workday
Related Documents
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831
De Servi, S. 2001: Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(7): 805-806
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Heptinstall, S.; May, J.A.; Glenn, J.R.; Sanderson, H.M.; Dickinson, J.P.; Wilcox, R.G. 1995: Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood Thrombosis and Haemostasis 74(5): 1310-1315
Lonsdorfer, J.; Castaigne, J.P.; Lenormand, E.; Otayeck, A.; Bogui, P.; Dosso, Y.; Cabannes, R. 1984: Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis Agents and Actions. Supplements 15: 213-218
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Saito, A.; Yamaji, T.; Saigusa, M. 1986: Adverse effects of antimicrobiological agents and countermeasures--TDM and countermeasures against adverse effects Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 955-958
Kohga, S.; Kinjo, M.; Tanaka, K.; Ogawa, H.; Ishihara, M.; Tanaka, N. 1981: Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis Cancer Research 41(11 Part 1): 4710-4714
Iovine, C.; d'Avenia, V.; Turco, S.; Mattioli, P.L.; di Minno, G. 1984: Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation Agents and Actions. Supplements 15: 105-107
Sriswasdi, C.; Jootar, S.; Giles, F.J. 2000: Amifostine and hematologic effects Journal of the Medical Association of Thailand 83(4): 374-382
Gastineau, D.A.; Hoagland, H.C. 1992: Hematologic effects of chemotherapy Seminars in Oncology 19(5): 543-550
Gazenko, O.G.; Shumakov, V.I.; Kakurin, L.I.; Katkov, V.E.; Chestukhin, V.V.; Nikolayenko, E.M.; Gvozdev, S.V.; Rumyantsev, V.V.; Vasilyev, V.K. 1982: Effects of various countermeasures against the adverse effects of weightlessness on central circulation in the healthy man Aviation Space and Environmental Medicine 53(6): 523-530
Futami, H.; Jansen, R.; MacPhee, M.J.; Keller, J.; McCormick, K.; Longo, D.L.; Oppenheim, J.J.; Ruscetti, F.W.; Wiltrout, R.H. 1990: Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy Journal of Immunology 145(12): 4121-4130
Nilsson, P. 2000: Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension Lakartidningen 97(35): 3710-3712
Bahr, F.R. 2009: Adverse acupuncture effects. "It is a case of malpractice and not side effects" MMW Fortschritte der Medizin 151(39): 7
Abels, R. 1990: Review of hematologic effects of erythropoietin Seminars in Nephrology 10(2 Suppl. 1): 1-10